covabio_developability
Assess biopharmaceutical developability across 8 risk dimensions: aggregation propensity, deamidation hotspots, oxidation sites, glycosylation risk, charge heterogeneity, hydrophobic patches, sequence liabilities, and post-translational modification risk. Returns composite score (0-100) with per-dimension breakdown and flagged positions.
Parameters:
sequence: Protein/antibody amino acid sequence.
metal_binding_context: Set True for chelators/metal-binding constructs so functional
Cys/His/carboxylate residues aren't penalized as liabilities (default False).
Returns: {composite_score, risk_dimensions: {aggregation, deamidation, ...}, flagged_positions}Tool call template
Replace each placeholder with a value matching the input schema. Only required parameters are included; add optional parameters as needed.
{
"id": 1,
"jsonrpc": "2.0",
"method": "tools/call",
"params": {
"arguments": {
"sequence": "<sequence>"
},
"name": "covabio_developability"
}
}Input Schema
| Name | Required | Description | Default |
|---|---|---|---|
| api_key | No | ||
| sequence | Yes | ||
| metal_binding_context | No |
Output Schema
| Name | Required | Description | Default |
|---|---|---|---|
| result | Yes |